Mitsuhiro Takeno Selected Research

Dyspnea (Shortness of Breath)

1/2023

Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhiro Takeno Research Topics

Disease

9	Rheumatoid Arthritis 01/2023 - 04/2006
7	Oral Ulcer (Mouth Ulcer) 10/2022 - 11/2019
6	Behcet Syndrome (Behcet's Syndrome) 01/2024 - 12/2003
6	Inflammation (Inflammations) 12/2018 - 04/2006
5	Disease Progression 10/2020 - 02/2003
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 01/2016
3	Arthritis (Polyarthritis) 10/2022 - 01/2022
3	Ulcer 10/2022 - 06/2010
3	Nausea 09/2021 - 11/2019
3	Infections 09/2020 - 07/2011
2	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 06/2010
2	Pain (Aches) 01/2022 - 09/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2022 - 07/2021
2	Headache (Headaches) 09/2021 - 11/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2020 - 02/2013
2	Lung Neoplasms (Lung Cancer) 01/2010 - 02/2003
2	Tuberculosis (Tuberculoses) 05/2009 - 07/2007
1	Dyspnea (Shortness of Breath) 01/2023
1	Pulmonary Sarcoidosis 01/2023
1	Granuloma 01/2023
1	Oral Manifestations 10/2022
1	Skin Ulcer 10/2022
1	Erythema Nodosum 10/2022
1	digital ulcers 10/2022
1	Ischemia 10/2022
1	Gangrene 10/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Paralysis (Palsy) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2021
1	Necrosis 07/2021
1	Lymphoma (Lymphomas) 01/2021
1	Hypesthesia (Numbness) 01/2021
1	Iridocyclitis 01/2021
1	Dermatomyositis (Dermatopolymyositis) 09/2020
1	Diarrhea 11/2019
1	Myocarditis (Carditis) 01/2019
1	Respiratory Paralysis 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2018
1	Lupus Nephritis 10/2018
1	Communicable Diseases (Infectious Diseases) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2017
1	Autoimmune Diseases (Autoimmune Disease) 07/2017
1	Bacterial Pneumonia 07/2017
1	Thymoma (Thymic Carcinoma) 07/2017
1	Exfoliative Dermatitis (Erythroderma) 07/2017
1	Parotitis (Parotiditis) 01/2016
1	Multifocal fibrosclerosis 01/2016
1	Immunoglobulin G4-Related Disease 01/2016
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2016
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 07/2015
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 07/2015
1	Familial Mediterranean Fever (Periodic Disease) 05/2013
1	Hashimoto's encephalitis 02/2013

Drug/Important Bio-Agent (IBA)

7	apremilastIBA 10/2022 - 11/2019
5	Infliximab (Remicade)FDA Link 06/2023 - 12/2003
5	Heme Oxygenase-1IBA 05/2012 - 04/2006
4	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 09/2020
4	Interleukin-10 (Interleukin 10)IBA 12/2018 - 08/2010
3	Heme (Haem)IBA 10/2018 - 01/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 12/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2024 - 06/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 10/2020
2	SteroidsIBA 10/2022 - 07/2017
2	AntibodiesIBA 10/2022 - 02/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2021 - 01/2019
2	Rituximab (Mabthera)FDA Link 01/2021 - 07/2015
2	Biomarkers (Surrogate Marker)IBA 09/2020 - 10/2006
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 07/2015 - 10/2003
2	Tumor Necrosis Factor InhibitorsIBA 07/2011 - 02/2007
2	EnzymesIBA 05/2008 - 04/2006
1	nintedanibIBA 01/2023
1	Anti-Citrullinated Protein AntibodiesIBA 01/2023
1	Vasodilator Agents (Vasodilators)IBA 10/2022
1	AutoantibodiesIBA 10/2022
1	Contrast MediaIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	Colchicine FDA LinkGeneric 07/2021
1	HLA-A*26 antigenIBA 01/2021
1	Phosphodiesterase 4 InhibitorsIBA 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2019
1	InterferonsIBA 11/2018
1	Interferon Type IIBA 10/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	Immunoglobulins (Immunoglobulin)IBA 07/2017
1	HLA-B51 AntigenIBA 10/2016
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	CPNBDIBA 02/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Unithiol (DMPS)IBA 09/2013
1	Toll-Like Receptor 4IBA 05/2013

Therapy/Procedure

9	Therapeutics 01/2023 - 02/2003
1	Activities of Daily Living (ADL) 01/2022
1	Remission Induction 01/2021
1	Thymectomy 07/2017
1	Drug Therapy (Chemotherapy) 07/2017
1	Immunotherapy 02/2013